ORAGENICS, INC. Inventory Valuation Reserves
ORAGENICS, INC. (OGEN) had Inventory Valuation Reserves of $0 as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryValuationReserves · last filed 2017-02-27
- 2016-12-31: Inventory Valuation Reserves $0.00.
- 2016-09-30: Inventory Valuation Reserves $0.00.
- 2016-06-30: Inventory Valuation Reserves $0.00.
- 2016-03-31: Inventory Valuation Reserves $60.66K.
| Period end | Inventory Valuation Reserves | Inventory Valuation Reserves as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $60.66K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $60.66K 10-K · filed 2017-02-27 | |
| 2015-09-30 | $74.20K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $68.20K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $59.20K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $50.18K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $41.20K 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $42.70K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $34.70K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $31.46K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $22.00K 10-Q · filed 2013-10-25 | |
| 2013-06-30 | $13.00K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $178.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $253.07K 10-K · filed 2014-02-28 | |
| 2012-09-30 | $61.80K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $21.00K 10-Q · filed 2012-08-10 | |
| 2011-12-31 | $65.21K 10-K · filed 2013-03-26 | $65.00K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |